Lindahl advises Senzime AB on a directed new share issue of SEK 100 million
Lindahl has advised Senzime AB (publ) in connection with a directed new share issue that will provide the company with SEK 100 million before transaction costs.
The subscription price was determined through an accelerated bookbuilding process, with Carnegie Investment Bank acting as financial adviser.
About Senzime
Senzime AB is a company listed on Nasdaq Stockholm that develops and markets CE and FDA approved monitoring systems for patients undergoing anaesthesia.
Lindahl's team consisted of Mattias Prage, Andreas Mellberg and Michaela Larsson.
Do you want to know more? Contact:
Mattias Prage
Partner | AdvokatMichaela Larsson
Associate | AdvokatAndreas Mellberg
Counsel | AdvokatCarousel items
-
Cases and transactions
5/6/2026
Lindahl advises Equistone Partners Europe on the sale of BUKO Group
Lindahl, together with Clifford Chance, advises Equistone Partners Europe on the sale of BUKO Group to Groupe Bruxelles Lambert.
-
Knowledge
5/6/2026
A reformed environmental law – what you need to know
Swedish environmental law is undergoing a historic reform. Learn what the new Environmental Permit Authority, revised review tracks and shorter appeal chains mean for your operations – and what you need to do now.
-
News articles
5/4/2026
Johan Norderyd named Practitioner of the Year at the Managing IP Awards
Johan Norderyd has been named the winner in the Sweden Practitioner of the Year (Law Firms) category at the Managing IP EMEA Awards 2026.
-
Portraits
1/20/2026
How I use AI in my daily work as a lawyer
AI is no longer the future – it is everyday reality. Johanna Karlsson, lawyer and senior associate at Lindahl, talks about how AI tools such as Legora have become a natural part of her workflow.
-
Read more news and insights?
